scorecardresearch
Add as a preferred source on Google
Sunday, November 2, 2025
TopicHIV

Topic: HIV

Eliminating AIDS has been an uphill battle. But Melbourne researchers just got one step closer

Bengaluru: Eliminating AIDS is a Sisyphian challenge. Treatments mostly miss the Human Immunodeficiency Virus (HIV) that are hidden in the body. But in a...

What is Hyderabad’s role in global acetone trade? New book explores the city beyond biryani

In 'Beyond Biryani', journalist Dinesh C Sharma unpacks the city's identity beyond its clichés and stereotypes, highlighting its contributions to industrial & scientific breakthroughs.

Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir

Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to affordable generics in India, warn civil society organisations.

Meth addiction, HIV, and a struggling health system plague Fiji as tourism grows

With children as young as nine being treated for addiction, and with crime statistics and HIV and AIDS cases climbing dramatically, police have called for a state of emergency.

Llama nanobodies can target HIV-1 strains & Sun starts next solar cycle halfway throught current one

ScientiFix, our weekly feature, offers you a summary of the top global science stories of the week, with links to their sources.

Hope like never before — a drug that promises 100% protection from HIV

Lenacapavir, developed by Gilead Sciences, was tested as a pre-exposure prophylaxis in African women & is now being tested in other groups who are among the most vulnerable to HIV.

Global life expectancy on the rise — men and women to live more than 4 years longer by 2050

ScientiFix, our weekly feature, offers you a summary of the top global science stories of the week, with links to their sources.

New lead for AIDS treatment? IISER scientists identify circular RNA that helps HIV-1 virus multiply

Findings published in journal Science Advances. The scientists have also developed a protein molecule that can reduce the multiplication of the HIV virus.

‘Rendered him cynical’ — SC orders IAF to compensate veteran who got HIV after 2002 blood transfusion

Overturning NCDRC ruling, bench says 'no amount of compensation & monetary terms can undo harm caused by services' behaviour which has shaken foundation of appellant’s dignity'.

New hope for HIV cure: Dual gene editing ‘eliminates’ infection, targets protein that helps virus enter body

US study published in Proceedings of the National Academy of Sciences. Therapy administered to mice engrafted with human T cells resulted in suppression of virus & elimination of HIV-1.

On Camera

Why fruity men are winning hearts on dating apps—it’s survival of the softest

An average single girl likes men who care about women’s cricket, skip the ‘harmless sexist jokes’ and listen to them rant without offering solutions. She still might call him a ‘performative male’ for ticking every box.

Consumer Price Index gets up to date. Airfare, OTT plans, e-commerce prices in new basket—MoSPI secy

New CPI series will take 2024 as base year, will provide more accurate measure of inflation, spending on digital services. Expected to enhance representation and reliability, says Saurabh Garg.

Joint production, closer ties, emerging tech: The foundation of new defence pact between India & US

The agreement, signed after meeting between Rajnath and US Secretary of War Pete Hegseth on sidelines of ADMM-Plus in Kuala Lumpur, aims to deepen bilateral ties in the critical sector.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.